NSAH?
CAS No. 1099592-35-4
NSAH? ( 2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide )
产品货号. M22882 CAS No. 1099592-35-4
NSAH 是一种人核糖核苷酸还原酶 (hRR) 的非核苷抑制剂。无细胞 IC50 为 32 μM,基于细胞的 IC50 约为 250 nM。萘基水杨酰腙 (NSAH) 是一种独特的非核苷小分子 hRR 抑制剂,使用虚拟筛选、结合亲和力、抑制和细胞毒性测定。 NSAH 与 hRRM1 结合的表观解离常数为 37 μM,稳态动力学揭示了竞争性抑制模式。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥629 | 有现货 |
|
| 10MG | ¥1102 | 有现货 |
|
| 25MG | ¥2000 | 有现货 |
|
| 50MG | ¥3004 | 有现货 |
|
| 100MG | ¥4365 | 有现货 |
|
| 200MG | ¥6057 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥692 | 有现货 |
|
生物学信息
-
产品名称NSAH?
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NSAH 是一种人核糖核苷酸还原酶 (hRR) 的非核苷抑制剂。无细胞 IC50 为 32 μM,基于细胞的 IC50 约为 250 nM。萘基水杨酰腙 (NSAH) 是一种独特的非核苷小分子 hRR 抑制剂,使用虚拟筛选、结合亲和力、抑制和细胞毒性测定。 NSAH 与 hRRM1 结合的表观解离常数为 37 μM,稳态动力学揭示了竞争性抑制模式。
-
产品描述NSAH is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively.A unique nonnucleoside small-molecule hRR inhibitor, naphthyl salicylic acyl hydrazone (NSAH), using virtual screening, binding affinity, inhibition, and cell toxicity assays.?NSAH binds to hRRM1 with an apparent dissociation constant of 37 μM, and steady-state kinetics reveal a competitive mode of inhibition.?A 2.66-? resolution crystal structure of NSAH in complex with hRRM1 demonstrates that NSAH functions by binding at the catalytic site (C-site) where it makes both common and unique contacts with the enzyme compared with NDP substrates.?Importantly, the IC for NSAH is within twofold of gemcitabine for growth inhibition of multiple cancer cell lines, while demonstrating little cytotoxicity against normal mobilized peripheral blood progenitor cells.?NSAH depresses dGTP and dATP levels in the dNTP pool causing S-phase arrest, providing evidence for RR inhibition in cells.NSAH (0-10 μM, 2, 6, 24, or 72 h) exhibits potent anti-tumor activity in 3 cancer cell lines.
-
体外实验NSAH depresses dGTP and dATP levels in the dNTP pool causing S-phase arrest, providing evidence for RR inhibition in cells.NSAH (0-10 μM, 2, 6, 24, or 72 h) exhibits potent anti-tumor activity in 3 cancer cell lines.NSAH blocks S-phase progression well to the extent and timing of the decreases in dATP and dGTP. Cell Viability Assay Cell Line:MDA-231, HCT116 and Panc1 cancer cell lines.Concentration:0-10 μM.Incubation Time:2, 6, 24, or 72 h.Result:Resulted in IC50 values ranging from 220 to 500 nM.
-
体内实验——
-
同义词2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide
-
通路Cell Cycle/DNA Damage
-
靶点DNA/RNA Synthesis
-
受体RR
-
研究领域——
-
适应症——
化学信息
-
CAS Number1099592-35-4
-
分子量306.3
-
分子式C18H14N2O3
-
纯度>98% (HPLC)
-
溶解度DMSO:62.5 mg/mL (204.03 mM; Need ultrasonic)
-
SMILESO=C(C1=CC=CC=C1O)N/N=C/C2=C3C=CC=CC3=CC=C2O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Md Faiz Ahmad, et al. Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8241-8246.
产品手册
关联产品
-
Syk Inhibitor II
Syk 抑制剂 II 是一种细胞渗透性、ATP 竞争性嘧啶-甲酰胺化合物,选择性且可逆地抑制 Syk (IC50 = 41 nM)。
-
BVDV-IN-1
BVDV-IN-1 是牛病毒性腹泻病毒 (BVDV) 的非核苷抑制剂 (NNI),EC50 为 1.8 μM。它直接结合 BVDV RdRp 的疏水口袋。
-
VVD-214
VVD-214 (RO7589831) is a WRN deconjugating enzyme lethal variant inhibitor with potential antitumor activity, inhibits ATP hydrolysis and deconjugating enzyme activity, and can be used in the study of proliferative diseases.
021-51111890
购物车()
sales@molnova.cn

